Panacea Biotec Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	-83.7	-11.73	-332.37	10,783	-1,477
Depreciation & Amortization	324.58	344.31	388.61	430.34	447.76
Other Amortization	23.56	22.8	2.62	7.43	8.18
Loss (Gain) From Sale of Assets	-4.46	45.59	-22.99	-0.07	0.38
Asset Writedown & Restructuring Costs	13.95	51.57	-	15.75	42.63
Loss (Gain) From Sale of Investments	-24.5	-33.67	-	-	-
Loss (Gain) on Equity Investments	-	-	-	-	-0.77
Provision & Write-off of Bad Debts	13.29	5.66	23.87	8.98	23.29
Other Operating Activities	-450.6	-492.17	-915.15	-15,339	1,807
Change in Accounts Receivable	-158.42	29.56	68.94	-463.4	-168.57
Change in Inventory	-357.36	241.58	106.3	-385.8	-264.45
Change in Other Net Operating Assets	429.97	-168.82	-3,544	3,858	652.1
Operating Cash Flow	-273.69	34.68	-4,225	-1,084	1,067
Capital Expenditures	-503.05	-828.76	-409.46	-125.1	-217.63
Sale of Property, Plant & Equipment	5.75	66.83	395.05	20	42.56
Divestitures	-	-	-	18,220	-
Investment in Securities	1,029	695.15	4,197	-5,322	-336.03
Other Investing Activities	117.84	133.37	120.62	32.8	34.31
Investing Cash Flow	649.84	66.59	4,303	12,826	-476.79
Long-Term Debt Issued	-	-	-	2.96	1,012
Total Debt Issued	-	-	-	2.96	1,012
Short-Term Debt Repaid	-	-	-	-	-35.68
Long-Term Debt Repaid	-	-2.36	-147.74	-7,864	-453.46
Total Debt Repaid	-	-2.36	-147.74	-7,864	-489.14
Net Debt Issued (Repaid)	-	-2.36	-147.74	-7,861	522.86
Other Financing Activities	-26.64	-25.72	-35.99	-3,898	-993.96
Financing Cash Flow	-26.64	-28.08	-183.73	-11,759	-471.1
Foreign Exchange Rate Adjustments	-	0.03	-0.04	-0.13	-
Net Cash Flow	349.51	73.22	-104.98	-17.42	118.61
Free Cash Flow	-776.74	-794.08	-4,634	-1,210	848.87
Free Cash Flow Margin	-13.89%	-14.20%	-100.75%	-18.29%	13.59%
Free Cash Flow Per Share	-12.68	-12.96	-75.66	-19.75	13.86
Cash Interest Paid	26.64	25.72	35.99	3,898	993.96
Cash Income Tax Paid	9.69	25.06	24.77	4,037	9.95
Levered Free Cash Flow	-741.96	-753.09	-4,293	2,811	1,882
Unlevered Free Cash Flow	-723.69	-736.38	-4,269	3,935	3,037
Change in Working Capital	-85.81	102.32	-3,369	3,009	219.08

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.